chrisvoncsefalvay/vaers-outcomes huggingface dataset:
battling bi-lateral wrist pain; swelling since her 2nd shot; This is a spontaneous report from a contactable consumer (reporter's niece).   A 50-years-old not-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), unspecified route of administration as dose 2, single covid-19 immunisation. Patient had no known allergies. The patient medical history included ongoing systemic lupus erythematosus, sjogren's syndrome from 2017 and ongoing and autoimmune syndromes ongoing. The patient family history Auto immune disorders ongoing (My family relations, who also suffer with auto immune disorders). The patient concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 1, single for covid-19 immunization. The patient had been battling bi-lateral wrist pain and swelling since her 2nd shot. She spoke with her the other day and learned she had similar symptoms. She suffers from sjogren's and lupus. The outcome of events was not recovered.  The lot number for the vaccine, was not provided and will be requested during follow up.
After the 2nd dose , I had fatigue and heaviness for 24 hours.    After a week , Lower fore arm Bilateral. It started on the left arm. It was red , bumps and itchy. I thought like something bite me and grew and very itchy, I thought it was psoriasis . Its itchy and sore. I saw the doctor 15Jan2022. She said it might be a fungus.
HEADACHE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow up to request batch/lot numbers. No concomitant medications were reported. The company is unable to perform follow up to request batch number . On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
Initial reaction on the evening of 4/15 and through 4/17 was simply a sore arm. I apparently had a late-onset delayed reaction; as I woke up in the morning of 4/21 with "vaccination arm" (2x3" raised red, itchy patch on arm where injection was given. This expanded to an approximately 3x5" patch by 4/22, when I also experienced significant fatigue for the entire afternoon and evening. Fatigue resolved by morning of 4/23; puffiness and itching completely subsided by 4/24; and redness has significantly faded.
The pt experienced vesicular lesions, no medications were ordered. The Varicella ran normal time course.
Developed on outer left thigh that was red, slightly indurated under the skin with 1 single vesicle.  Resolved on own.
muscle pain; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd September 2020, the patient received Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was not recovered/not resolved.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was vaccinated with Shingrix and experinced muscle pain. The patient read that the muscle pain should last 2 to 3 days. But patient stated that it has been over 2 months and the muscle pain was ongoing till reporting day. The reporter did not consent to follow up. Reporter provided limited information.
Patient received two doses of Moderna vaccine and requested a booster.  Pharmacist did not look as vaccine administration card before administering dose of Pfizer.
Four days of feeling sick with aches, pains, upset stomach. On day 2 he was so sick he thought he would die. Sudden death on day 7.
Shivering, stomach pain, fever at night for the first two nights (in day 1 and day 2 after getting vaccine).   Fever and shivering went away in a reasonable amount of time after taking Tylenol.  Stomach pain persisted through most of the night.   No fever or shivering on night 3.  Stomach pain mostly gone, like swelling has gone down but feel a slight reminder that some is still there.   Not enough to interrupt sleep like the first 2 nights or be of any significance.  Joint pain during first day.   Minor pain and redness at injection site for a couple of days.   Now only minor pain if touching the site directly (day 3).   Nothing of much significance in any of the days.
Approximately 2 hours after the JE (Ixiaro) vaccine patient developed a headache. The headache became "pretty severe" and lasted about 2 weeks in all. She also developed neck pain and stiffness. She says she isn't sure if the neck pain and stiffness may have been from her holding her neck stiff because the headache was bad. She saw her PCP and was evaluated in his office. PCP thought there was a chance at one point that she had a "mild case" of viral meningitis but was not concerned enough about this to send her to ER or for evaluation/LP for this. She went to physical therapy for her neck stiffness. She states she is mostly recovered at this point and headache and neck pain and stiffness are pretty much gone.
No adverse event; exposure via breast milk; drug exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (exposure via breast milk), MATERNAL EXPOSURE DURING PREGNANCY (drug exposure during pregnancy) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 3031283) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Pfizer on 08-May-2022, Pfizer Bivalent on 07-Oct-2022, Pneumonia on 01-Sep-2023 and Flu on 01-Sep-2023. Past adverse reactions to the above products included No adverse reaction with Flu, Pfizer, Pfizer Bivalent and Pneumonia. Concurrent medical conditions included Type 2 diabetes mellitus, Hypothyroidism and Hypertension.    On 23-Sep-2023, the patient received third dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) .5 milliliter. Last menstrual period and estimated date of delivery were not provided. On 23-Sep-2023, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (exposure via breast milk) and MATERNAL EXPOSURE DURING PREGNANCY (drug exposure during pregnancy). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). On 23-Sep-2023, MATERNAL EXPOSURE DURING BREAST FEEDING (exposure via breast milk) and MATERNAL EXPOSURE DURING PREGNANCY (drug exposure during pregnancy) had resolved. At the time of the report, NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for MATERNAL EXPOSURE DURING BREAST FEEDING (exposure via breast milk) and MATERNAL EXPOSURE DURING PREGNANCY (drug exposure during pregnancy).    Concomitant and treatment medications were not reported.  It was reported that HCP who administered a vaccine and administered it close to shoulder bone than it was suppose to be.  They need to call to see if the patient needs another vaccine or if it was fine the way it was administer it at that location. All of the medication went into the patient. HCP reports they used a prefilled syringe.  Company comment: This spontaneous case concerns a 56-year-old, female patient with medical history of type 2 diabetes mellitus, Hypothyroidism and Hypertension and no gynecological history reported, who experienced the unexpected non serious events of maternal exposure during pregnancy and maternal exposure during breast feeding. The events occurred on the same day after the third dose of SPIKEVAX 2023-2024 PFS. Date of patient's last menstrual period, expected delivery date, and gestational age at time of exposure were not provided. It was reported that HCP who administered a vaccine and administered it close to shoulder bone than it was suppose to be. No further information about the events was provided. The benefit-risk relationship of SPIKEVAX 2023-2024 PFS is not affected by this report.
I have not had a normal voice since the injection.  I have hand chronic illness since the injection. I do have seasonal allergies,  since the injection I have had many rounds of antibiotics and chronic loss of voice, my breathing is labored and I have been chronically ill.  I have been forced to work from home due to these illnesses.  After multiple doctor visits there seems to be no answer as to why I keep getting sick.
PC fr mom; pt restless, screaming x 3 hrs; big, red blotches over both feet; afebrile, no seizures; mom made pc to MD stated no pertussis on next shots;
Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Additional Details: Patient blacked out twice approximately 5 minutes following vaccine
pt recv vax; exp inject site rxn characterized by a 3" indurated area with erythema and warmth;  indurated area in to 5" in diam ; MD thinks may have recv a SC inject;
This patient tested positive for COVID19 on 12/28/20. The purpose of this VAERS submission is in response to the request from the agency to input all patients who tested positive for COVID19 after receipt of the COVID19 vaccine.
I began having a rapid heartbeat around 7pm.  At 9:30 pm decided to go to ER to be evaluated. After being seen, ecg, bloodwork and examination, I was told  I had sinus tachycardia. I went home around 3:00 am as my heart rate started to go down. Dr. told me this was an  adverse reaction to the vaccine after all other causes were ruled out.
Facial rash and itching developed and persisted to the next day, was seen in the emergency room and had some improvement after Benadryl and Pepcid given.
Expired Product Used; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 34-year-old female patient who received HBV (Engerix B) (batch number F73DG, expiry date 03-JUL-2023) for prophylaxis.   On 27-JUL-2023, the patient received the 1st dose of Engerix B. On 27-JUL-2023, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Expired Product Used). The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 31-JUL-2023 A medical assistant thought that this was the patient's first dose in the series, however she was not certain.  At the time of reporting, the dose had not been repeated.  The reporter consented to follow up. The patient received an expired dose of Engerix-B vaccine which led to expired vaccine used.
Numbness; Tingling in her hands and legs; Legs are achy; Vertigo; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of VERTIGO (Vertigo), HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling in her hands and legs), NAUSEA (Nausea) and MYALGIA (Legs are achy) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced VERTIGO (Vertigo) and NAUSEA (Nausea). On 04-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling in her hands and legs) and MYALGIA (Legs are achy). The patient was treated with DIPHENHYDRAMINE for Adverse event, at an unspecified dose and frequency. At the time of the report, VERTIGO (Vertigo), HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling in her hands and legs), NAUSEA (Nausea) and MYALGIA (Legs are achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non significant follow up received. Email address updated.
Patient became dizzy approximately 10 minutes after vaccine.  She had a syncopic episode accompanied by seizure like activity that lasted about 10 seconds.  Once she regained consciousness, she was disoriented for about 1 minute.    Within 3 minutes of regaining consciousness she had nausea and subsequent vomiting X2.  HR 63, BP 117/70, O2 SAT 96% on room air.  Zofran 4mg SL was administered.   Patient evaluated by the Mass Vax Site physician. Patient recovered quickly, refused further medical treatment and was accompanied home by her mother who was with her during the event.
Severe Headache, arm pain at the site of injection/ body aches, chills, fatigue
Patient states injection given too high on the shoulder. Result was inhibited range of motion with shoulder pain. States he has had other immunizations without this type of pain.
pt recvd vax;irritability;unsure if had sz; was jerking all over,lasting about 1 min;did not lose conciousness;also had blue around mouth;lasted 5 mins;was quiet;not  crying or sleeping;
Redness, swelling and itching at site of vaccination started 2 days after. Seen by MD 12/8/14 and swelling measured 3 inches in diameter. 12/9/14 patient reports much improvement. Treatment: BENADRYL, Hydroxyzine, CLARITIN.
Left arm red, hard, tender to touch. Itching, tingly, slight numbness intermittent through arm. 4"x2" area of erythema.
Patient went to the ER the morning after receiving the vaccine because she reports she was experiencing a severe migraine with ear and eye pain, nausea, vomiting, diarrhea, pain in hands and feet, and muscle spasms that last for 4 days.
Morning of May 19, saw hives in fairly solid  firm raised area approx. 3"x 2" across side of arm, mid way between injection site and elbow. Area was warm to touch, itchy, red. Increased in size by next day. Started to go away by May 21. Greatly decreased by May 22.
On 9-15-23 a dose of Men B was given to an 11-year-old by one of the employees that was in training. The employee was trained on the situation and the parent was called and informed of the situation. The patient must come back to the office to receive the correct vaccination of Men-Quad.
Information has been received from a registered nurse, for GARDASIL,a Pregnancy Registry product, concerning a 17 years old female patient without drug reaction. The patient's current condition included vitamin D deficiency. The patient's history of previous pregnancies and live births is not known. The patient was vaccinated intramuscularly with the first, second and third dose of 0.5 ml GARDASIL (lot number unknown) on 08-SEP-2011, 08-NOV-2011 and 25-JUL-2012, respectively. No other co-suspects were reported. There were no concomitant medications. The patient became pregnant with an LMP of 26-MAY-2012 and an EDD of 02-MAR-2013. Initial exposure to GARDASIL was at 8 weeks. The patient was exposed to GARDASIL during trimester 1. The reporter stated that the date of the patient's menstrual period that the patient provided was incorrect, and therefore she was not suspected of benign pregnant when coming in to receive her third dose of GARDASIL on 25-JUL-2012. The reporter also noted that on 25-JUL-2012 at her office visit, the patient's primary complaint was of headaches and she was sent to neurology for evaluation. Laboratory diagnostics studies about routine blood work were performed and results were unknown. The patient had contacted physician for medical attention. The outcome was unknown. Additional information has been requested.
I was ordered by my employer to receive a flu shot. At the time off injection, I noticed that my injection was higher than where I've normally received them in the past- about two fingers width below the riding of my shoulder. Within hours of administration I began to experience severe pain and stiffness is my arm. Several days passed and the pain and lack of mobility remained. The intensity eventually subsidized, but I still experienced pain with motion. As time progressed, The pain began to increase. I started experiencing pain when dressing/undressing, turning my wheel while driving, and other basic tasks.  Nsaids and Tylenol had no effect when taken. On October 7th, I was in so much pain and experienced a decreased range of motion to the point I was unable to sweep my floor or open a jar. I went to urgent care that afternoon as I suspected that this was no longer within the realm of being a normal side effect.  I was advised that this may be a result of an improperly administered vaccine. I was also advised that this may be exacerbated by my Fibromyalgia.  I was prescribed Baclofen, given instructions to rotate with ice/heat, but to continue movement and do "spidercrawls" with my fingers. I did as instructed, but my condition not improve over the next week.  Today, October 18th, I saw PCP who acknowledged a likely improper administration and diagnosed me with a frozen shoulder. She has prescribed Meloxicam and referred me to physical therapy.
interval from the first shot was already 42 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (interval from the first shot was already 42 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (interval from the first shot was already 42 days). On 16-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (interval from the first shot was already 42 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information, if any, was not provided by the reporter.  Treatment information, if any, was not provided.
Reported both cheeks, chin and forehead and under right arm with redness, itching and slight swelling the next day after vaccines were administered. As of 7/27/09 the symptoms were improving. Instructed to call MD if symptoms worsen or continue after treatment with BENADRYL. No c/o SOB or other acute distress noted.
Severe arm pain x2 days - injected in shoulder not deltoid Sudden onset of chills, severe shaking, shortness of breath, 02 sat = 89% that lasted 15 minutes (took Tylenol 1000 mg immediately).  This occurred about 1.5 days after injection
Approx. 40 minutes after receiving vaccines on 9-14-11, client's mother reported that client started vomiting, c/o abdominal pain, headache, and runny nose. She took client to the ER for eval. No treatment given. Mother to observe. Mother will call with follow-up info on 9-16-11.
Left arm pain for the past days and now swollen/enlarged (central) armpit lymph node  Migraine (left side but had similar symptoms - headaches/migraines on and off before)
The patient reports that he woke with the rash 2 days after his vaccine. The rash has not changed in size, shape, improved or worsened in the three days since it appeared. He has never had anything like this happen before. He denies any systemic symptoms. The rash is pruritic, and the pruritis has not been helped by his allergy medications or topical hydrocortisone.
Runny nose sore throat, body aches, chest hurting/coughing, sneezing/wheezing within 24 hrs of vaccine.
Throwing up Nausea chills and hot flashes fatifue body aches all over
arm from the area of the shot to her finger tips was swollen so bad; urinary issues; loss of energy; tingling in fingers; still swollen with pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm from the area of the shot to her finger tips was swollen so bad), URINARY INCONTINENCE (urinary issues), ASTHENIA (loss of energy), PARAESTHESIA (tingling in fingers) and PAIN IN EXTREMITY (still swollen with pain) in an 89-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In 2023, the patient experienced PERIPHERAL SWELLING (arm from the area of the shot to her finger tips was swollen so bad), URINARY INCONTINENCE (urinary issues), ASTHENIA (loss of energy), PARAESTHESIA (tingling in fingers) and PAIN IN EXTREMITY (still swollen with pain). In 2023, PERIPHERAL SWELLING (arm from the area of the shot to her finger tips was swollen so bad) had resolved. At the time of the report, URINARY INCONTINENCE (urinary issues), ASTHENIA (loss of energy), PARAESTHESIA (tingling in fingers) and PAIN IN EXTREMITY (still swollen with pain) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication and treatment were not provided.  Patient just received the latest covid shot. She woke up during the night and her arm from the area of the shot to her fingertips was swollen so bad she could go back to sleep, and the next day, still swollen with pain and tingling in fingers, and urinary issues and extreme loss of energy. It's been over a week, and the swelling is gone but still pain and tingling in fingers, and urinary issues and still no energy.   Most recent FOLLOW-UP information incorporated above includes: On 29-Oct-2023: Live fallow-up received with IRD 29-Oct-2023. reference number was updated.
Approx 10 minutes after injection, pt reported his lower checks were starting to itch and he felt a little swelling in his check bones. Pt also stated he wasn't having any trouble breaking, skin tone look normal, pt was able to communicate with no problems. He stated the symptoms he was experiencing were something he was used to. It happens to him when he eats chicken  and certain kinds of foods (especially seafood/shellfish). I offered him benadryl and an ice pack while he was here. He refused the ice pack, but did  agree to low dose of benadryl. He took one Allergy Relief 25mg softgel and then continued to set for a little over 30 minutes total before he said he was fine and left with his wife.  I contacted him around 11:50am, he was doing fine and enjoying a good lunch.
A pediatrician reported that a patient who had a medical history of solid organ transplantation received a dose of Pnu-Imune-23 on 03/04/02. That day, 4.5 hours post vaccination, the patient developed an injection site reaction characterized by a  50 mm area of swelling, a 90 mm by 35 mm area of redness, and "severe" tenderness to palpation. The reporter indicated that the patient was unable to attend school on 03/05/02. The symptoms resolved completely on 03/06/02. FOLLOW-UP information was received from the physician on 04/04/02. The child had a medical history of heart transplantation. Concomitant medications included Prograf (tacrolimus) and trimethoprim/sulfamethoxazole).
Pt had acute local swelling redness & pain in (R) deltoid region 1 hour after PNEUMOVAX last pm. She took BENADRYL and it has improved some. Circumference at present 3/5 cm.
Throbbing, aching pain in right upper arm. Comes and goes. Wakes me up at night. Pain worsening lately.